(±)-Lucidumone (), an enantiomeric meroterpenoid possessing an unprecedented skeleton comprising a fused 6/5/6/6/5 polycyclic system, was isolated from and structurally identified. The absolute configuration of (-) was assigned by single-crystal X-ray crystallography. A plausible biosynthetic pathway for is proposed. A chemical biology approach reveals that (-)- selectively inhibits COX-2 by directly binding with an amino acid residue of Tyr385, representing a new structure scaffold of COX-2 inhibitors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.orglett.9b02840 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!